Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-004639
Filing Date
2025-06-26
Accepted
2025-06-26 16:25:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3400
  Complete submission text file 0001950047-25-004639.txt   5021
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Subject) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36913 | Film No.: 251080713
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 233 WILSHIRE BOULEVARD SUITE 280 SANTA MONICA CA 90401
Business Address
Thompson Rahsaan (Reporting) CIK: 0001788524 (see all company filings)

Type: 144